FDA Clarifies Exemption for Retail Sales of Pseudoephedrine and Phenylpropanolamine Products

Summary

The U.S. Food and Drug Administration (FDA) has issued a clarification on the exemption of sales by retail distributors of pseudoephedrine and phenylpropanolamine products, which are commonly used in over-the-counter cold and allergy medications.